← Open Payments lookup

KATHERINE OLMSTEAD: Open Payments

NPI 1699211029 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,166 in 46 payments from 16 companies in 2025. Trend: 2023 $432 · 2024 $462 · 2025 $1,166

Food & beverage: $1,166
CompanyPaymentsAmount
ABBVIE INC.17$397
ARS Pharmaceuticals Operations, Inc.1$149
Novo Nordisk Inc6$115
Takeda Pharmaceuticals U.S.A., Inc.4$100
PFIZER INC.3$67
GlaxoSmithKline, LLC.2$44
Astellas Pharma US Inc2$44
Exeltis, USA Inc.2$41
Pharmacosmos Therapeutics Inc.1$34
Exact Sciences Corporation1$31

Products named: VRAYLAR, NEFFY, QULIPTA, TRINTELLIX, Ozempic, AREXVY, Veozah, Wegovy.

Industry payments across PA — which companies pay providers there.